Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2009-06-02 21:21:03 UTC |
---|
Update Date | 2016-11-09 01:08:21 UTC |
---|
Accession Number | CHEM000714 |
---|
Identification |
---|
Common Name | Dichlorprop |
---|
Class | Small Molecule |
---|
Description | Dichlorprop is a chlorophenoxy herbicide similar in structure to 2,4-D that is used to kill annual and perennial broadleaf weeds. It is a component of many common weedkillers. About 4 million pounds of dichlorprop are used annually in the United States. (4) |
---|
Contaminant Sources | - Clean Air Act Chemicals
- HPV EPA Chemicals
- IARC Carcinogens Group 2B
- My Exposome Chemicals
- STOFF IDENT Compounds
- T3DB toxins
- ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | - Aromatic Hydrocarbon
- Ether
- Industrial/Workplace Toxin
- Lachrymator
- Organic Compound
- Organochloride
- Pesticide
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
2-(2,4-Dichlorophenoxy)propionic acid | ChEBI | 2-(2,4-Dichlorophenoxy)propionate | Generator | 2,4-DP CPD | MeSH | Dichloroprop | MeSH | Dichlorprop, (R)-isomer | MeSH | Dichlorprop, (S)-isomer | MeSH | 2-Methyl-2-(2',4'-dichlorophenoxy)acetic acid | MeSH | Dichlorprop, sodium salt | MeSH | 2-(2,4-Dichlorophenoxy)propanoic acid | MeSH | Dichlorprop, (+,-)-isomer | MeSH | Dichlorprop, potassium salt | MeSH |
|
---|
Chemical Formula | C9H8Cl2O3 |
---|
Average Molecular Mass | 235.064 g/mol |
---|
Monoisotopic Mass | 233.985 g/mol |
---|
CAS Registry Number | 120-36-5 |
---|
IUPAC Name | 2-(2,4-dichlorophenoxy)propanoic acid |
---|
Traditional Name | (+,-)-dichlorprop |
---|
SMILES | CC(OC1=CC=C(Cl)C=C1Cl)C(O)=O |
---|
InChI Identifier | InChI=1S/C9H8Cl2O3/c1-5(9(12)13)14-8-3-2-6(10)4-7(8)11/h2-5H,1H3,(H,12,13) |
---|
InChI Key | MZHCENGPTKEIGP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as 2-phenoxypropionic acids. These are aromatic compounds hat contain a phenol ether attached to the C2-atom of a phenylpropionic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | 2-phenoxypropionic acids |
---|
Direct Parent | 2-phenoxypropionic acids |
---|
Alternative Parents | |
---|
Substituents | - 2-phenoxypropionic acid
- Phenoxyacetate
- Phenoxy compound
- Phenol ether
- 1,3-dichlorobenzene
- Alkyl aryl ether
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Monocarboxylic acid or derivatives
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Organochloride
- Organic oxide
- Organohalogen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 122°C | Boiling Point | Not Available | Solubility | 0.35 mg/mL at 20°C [WORTHING,CR & WALKER,SB (1987)] |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-03di-3900000000-8c34b228fd37a85535b8 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_1) - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 35V, Negative | splash10-03di-0900000000-0bc46b559148e22b319e | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 35V, Negative | splash10-03di-0900000000-98157a7e40d20e0cc425 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 35V, Negative | splash10-03di-0900000000-f62223c14a643777c106 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 15V, Negative | splash10-03di-0900000000-85339d24500504db1216 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 90V, Negative | splash10-03k9-2900000000-433a8fa2b5be5d869baf | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 90V, Negative | splash10-03k9-1900000000-c28d310a891e98419d3a | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Negative | splash10-03di-0900000000-b028c8fd701fd204d081 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 45V, Negative | splash10-03di-0900000000-e9b0d6314e8f95d8097f | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 75V, Negative | splash10-03di-0900000000-d838e2b8d0cfeb83e046 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 60V, Negative | splash10-03di-0900000000-ef612253eae93e3d704f | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 45V, Negative | splash10-03di-0900000000-0d84de9a0092db340238 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 15V, Negative | splash10-03di-0900000000-e13a5965f29a56e7ee90 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 60V, Negative | splash10-03di-0900000000-e8e24b900c37b7dc2b46 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 75V, Negative | splash10-03di-0900000000-619ce3657149bfea3bb6 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00lr-0290000000-47f6045622f1b0ed0183 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-2930000000-36cb4444e42220d8edad | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03di-2900000000-dc9e1ef71abf99817bb8 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-0290000000-dd659f39fc34ba438c3f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03e9-0940000000-820a445e6d46f09be9d8 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-03di-0900000000-27642267b16dcefc91bf | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00lr-0190000000-9d334d56eabd92b70213 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0900000000-939ea75dee09b3cdd6cd | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03dl-3900000000-dc8501239c432d4713bb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03ei-1920000000-8bc044ac57be5ef3bb6f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03e9-4900000000-d8c513da7771ff3460e3 | Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-03di-1920000000-677b5256e04a2a1174bf | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | CDDs cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. This includes 2,3,7,8-tetrachlorodibenzo-p-dioxin's carcinogenicity is thought to be the result of its ability to alter the capacity of both exogenous and endogenous substances to damage the DNA by inducing CYP1A1- and CYP1A2-dependent drug-metabolizing enzymes. (1) |
---|
Metabolism | CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing CDDs induce both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the feces, though smaller amounts are excreted in the urine and via lactation. (1) |
---|
Toxicity Values | LD50: 344 mg/kg (Oral, Rat) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | 2B, possibly carcinogenic to humans. (5) |
---|
Uses/Sources | Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (1, 2) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | It is considered to be a severe eye irritant. There has been concern that chlorophenoxy herbicides including dichlorprop may cause cancer, and in 1987 the International Agency for Research on Cancer (IARC) ranked this class of compounds as group 2B "possibly carcinogenic to humans". The EPA classifies the R-isomer as “Not Likely to be Carcinogenic to Humans.”(4) Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathology, thyroid disorders, endometriosis, and diabetes. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is also a known human carcinogen. (1, 2) |
---|
Symptoms | In addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (1) |
---|
Treatment | Treatment may include washing any areas of contact, GI decontamination if swallowed, administering an IV and forced alkaline diuresis. (3) |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Dichlorprop |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | 75370 |
---|
PubChem Compound ID | 8427 |
---|
Kegg Compound ID | C11020 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|